Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with low-dose ribavirin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with low-dose ribavirin, covering 2017-10-18 to 2017-10-18. Get the full timeline:
Most recent: Clinical Trial Update: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection [Phase 3]